Researchers develop novel AI-based estimator for manufacturing medicine
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
The chatbot’s success on the medical licensing exam shows that the test — and medical education — are flawed, Celi says.